Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shake or run? study tests best exercise after kidney transplant

NCT ID NCT07333105

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at two types of exercise—whole body vibration and aerobic training—in 60 adults who had a kidney transplant. The goal was to see which one better improved endurance and reduced a marker of inflammation called interleukin-6. Participants were between 30 and 45 years old and had no other major health issues. The results help guide post-transplant rehabilitation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients of both sexes undergone renal transplantation. * Their age will range from 30-45 years old. * All patients will have the same medical and nursing care. * All the patients will receive a good explanation of treatment and measurement device. * They will be free from any genitourinary infections. * They will be neurologically free. Exclusion Criteria: * Uncooperative patients * Instability of patient's medical condition. * Association of another medical problem as heart disease and respiratory problems. * Diabetic patients. * Patients who have history of medical chronic relevant diseases. * Patients who have acute or chronic hepatitis. * Patients have pacemaker. * Patients who have genitourinary infections. * Previous history of epilepsy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aerobic training are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alkahraba Hospital in Cairo

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.